Lilly says Cialis is gaining on Viagra

Share this article:
Eli Lilly said Cialis is gaining market share from the top-selling erectile dysfunction (ED) drug, Pfizer’s Viagra. Cialis has gained more than 3% of global market share between July 2005 and July 2006, Lilly said during a presentation to analysts. Sales of Cialis continue to grow in most markets around the globe, including the US, Europe and Latin America. Cialis is on track to be the No. 1 ED drug worldwide -- excluding the US -- by next year, Lilly said. Viagra had 49.3% of the global market as of July, while Cialis had 35.5%, Lilly said. Third-place Levitra, made by GlaxoSmithKline, had about 15.3% of the market. Lilly did not make any claims for overtaking Viagra inside the US, where Viagra holds 58% of the market, compared with 25% for Cialis, Worldwide, Cialis sales are expected to top $1 billion in 2007, which would make it one of Lilly's top five drugs. Cialis is a top-selling ED drug in 17 countries, including France, where it is commonly referred to as "le weekender." Lilly will launch Cialis next year in Japan. Lilly is buying its Cialis marketing partner, Seattle-based Icos, for about $2.1 billion. Cialis' patent does not expire until 2017.
Share this article:

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.